Please login to the form below

Not currently logged in
Email:
Password:

market access

This page shows the latest market access news and features for those working in and with pharma, biotech and healthcare.

Brexit to blame as firm plans to leave UK for Ireland

Brexit to blame as firm plans to leave UK for Ireland

However the mood in the sector is low, with Brexit’s many downsides combining with market access restrictions to make the UK unattractive compared to other locations.

Latest news

  • MPs threaten to publish Vertex’s Orkambi price if no deal struck MPs threaten to publish Vertex’s Orkambi price if no deal struck

    As the UK is used as a reference pricing market by many other countries, revealing its actual price offer would damage its negotiating position around the world. ... Confidential price discounts have become a routine part of the NICE and NHS England

  • Symkevi approval in Europe helps Vertex expand CF treatment Symkevi approval in Europe helps Vertex expand CF treatment

    Gaining market access in Europe is far from straightforward however, especially in England, home to one of the highest numbers of CF patients anywhere in the world. ... Vertex has been in an ugly standoff with budget holder NHS England over pricing and

  • Amgen CEO says Aimovig is “one of most successful launches” Amgen CEO says Aimovig is “one of most successful launches”

    device, as well as a willingness by healthcare payers to cover the product thanks to a price that encourages access. ... Commenting on the overall environment and how it looks likely to develop in 2019, Bradway said that the US has benefitted enormously

  • MS and cholesterol drugs picked for new UK rapid uptake push MS and cholesterol drugs picked for new UK rapid uptake push

    The medicines have been chosen by the Accelerated Access Collaborative (ACC) a new initiative aimed at speeding up access to healthcare innovation which could improve patient care and prove to be ... While the ACC’s first rapid uptake list is welcome

  • Gilead strikes deal with NHS England on CAR-T Yescarta

    Gilead strikes deal with NHS England on CAR-T Yescarta. NHS England claims adult leukaemia access is first in Europe. ... NHS England has agreed a market access deal with Gilead for its groundbreaking CAR-T therapy Yescarta, and is claiming it to be the

More from news
Approximately 127 fully matching, plus 446 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    However in the most valuable sub-sector of the market, immuno-oncology, the company is struggling to make major inroads. ... These battles over pricing and access in the US market remain among the biggest priorities for Pfizer and its big pharma peers.

  • Pharma: in search of the sustainable ‘win win’ with the NHS Pharma: in search of the sustainable ‘win win’ with the NHS

    Ahead of the meeting, I caught up with one of our industry speakers, Fiona Bride, head of UK market access strategy at Novartis. ... Update: Ewan  Barbour, Market Access and Pricing Director at Merck will also be speaking at the event.

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    and its rivals on these measures will undoubtedly be the focus in the market. ... Heggie says country by country conversations on market access are well under way in Europe.

  • Lonely planet: why there is dwindling value in pharma travelling alone Lonely planet: why there is dwindling value in pharma travelling alone

    medical or market access teams. ... How do we move the access story from one that’s economically- led, perfunctory and transactional, to one that’s much more emotive?

  • KAM 2.0 KAM 2.0

    So, how does a Key Account Manager (KAM) in one market approach this kind of super account? ... Cross-functional buy-in is essential – KAMs should tap into medical, marketing and market access, as well as sales – but again this is a mindset and

More from intelligence
Approximately 54 fully matching, plus 120 partially matching documents found.

Latest appointments

  • New starters join Four Communications, Emotive and McCann Health New starters join Four Communications, Emotive and McCann Health

    Jones, who also joins the Four Communications Group operating board, joined the team in 2012, and has worked across the company’s market access, corporate communications and campaign functions. ... Cambers joined Insight back in 2009, and specialises

  • Weekly comms appointments Weekly comms appointments

    market access practices.

  • PropPharma selects new CEO and president PropPharma selects new CEO and president

    She has also held the role of chief operating officer for Teva Pharmaceuticals, where her focus included strategy and innovation for patient solutions, commercial effectiveness, market access, business insights and market

  • Open Access Consulting appoints new director Open Access Consulting appoints new director

    Hurrell joins the group from Evidera, where she worked for over a decade, most recently as vice president and EU practice lead, market access communications. ... In this role, Hurrell oversaw the team’s market access communications offering, supporting

  • Claes Buxfeldt joins NDA Claes Buxfeldt joins NDA

    He has represented the payer voice in development programmes including the development of payer evidence strategies, pricing, market access strategy, economic models and clinical programme input.

More from appointments
Approximately 4 fully matching, plus 87 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 31 fully matching, plus 19 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics